Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-06

FDA Approved: HUMALOG KWIKPEN — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for Humalog KwikPen (insulin lispro) from Eli Lilly and Company. The approval likely covers changes to labeling or other…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HUMALOG KWIKPEN (insulin lispro)

Snippet

SUPPL AP for HUMALOG KWIKPEN (INSULIN LISPRO)